Insider Transactions

Date Name Title Filing Type Shares Traded Price Range Total Held
Feb 01, 2019 SVP Global Operations and R&D Form 3 Initial Statement of Beneficial Ownership of Securities -- -- --
Feb 12, 2019 SVP and GM of Oncology Form 4 Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 490 $22.90 13,543
Apr 04, 2019 Director, President and CEO Form 4 Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 4,232 $22.95 121,476
Apr 24, 2019 SVP and General Counsel Form 4 Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 1,319 $20.64 35,235
May 23, 2019 SVP/GM, Vascular Access Form 4 Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 858 $19.15 16,650
May 31, 2019 Director Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 6,650 $10.68 87,628
May 31, 2019 Director Form 4 Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 3,780 $18.79 83,848
May 31, 2019 Director Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 6,650 -- --
Jun 28, 2019 Director Form 4/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 6,650 $10.68 87,628
Jun 28, 2019 Director Form 4/A Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 3,607 $19.69 84,021
 For recent transactions, including derivative transactions, see our Section 16 SEC filings page.